Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial - Kris,M.G.; Natale,R.B.; Herbst,R.S. (JAMA, 2003)